Back to Search
Start Over
Icosavax plans to file IND submission and initiate a Phase 1 trial for IVX-A1
- Source :
- The Fly. June 28, 2022
- Publication Year :
- 2022
-
Abstract
- Icosavax announced positive topline interim results from its Phase 1/1b clinical trial of IVX-121, a VLP displaying a prefusion stabilized Respiratory Syncytial Virus RSV F antigen, in young and older [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.708500753